BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2426902)

  • 1. Calmodulin levels in psoriasis: the effect of treatment.
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    Acta Derm Venereol; 1986; 66(3):241-4. PubMed ID: 2426902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal calmodulin levels in psoriasis before & after therapy.
    Kaur I; Kaur S; Vaishnavi C; Ganguly NK; Garg J; Kohli M
    Indian J Med Res; 1991 Apr; 94():130-3. PubMed ID: 1879887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
    Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
    Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calmodulin content of the epidermis in psoriasis.
    Mac Neil S; Tucker WF; Dawson RA; Bleehen SS; Tomlinson S
    Clin Sci (Lond); 1985 Dec; 69(6):681-8. PubMed ID: 4064579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
    Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
    Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical interferon-alpha in psoriasis increases epidermal calmodulin activity.
    Wollina U; Knopf B; Klinger R
    Arch Dermatol Res; 1990; 282(4):270-1. PubMed ID: 2372219
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
    Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T
    J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy.
    Fransson J; Ros AM
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):326-32. PubMed ID: 16313245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of epidermal cellular DNA content and its clinical significance in psoriasis vulgaris.
    Zhu KJ; Zhu TC
    J Dermatol; 1995 Jun; 22(6):419-23. PubMed ID: 7650240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histochemical analysis of macrophage migration inhibitory factor in psoriasis vulgaris.
    Shimizu T; Nishihira J; Mizue Y; Nakamura H; Abe R; Watanabe H; Ishibashi T; Shimizu H
    Histochem Cell Biol; 2002 Sep; 118(3):251-7. PubMed ID: 12271361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature of cell kinetics in psoriatic epidermis.
    Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis.
    Peltonen S; Riehokainen J; Pummi K; Peltonen J
    Br J Dermatol; 2007 Mar; 156(3):466-72. PubMed ID: 17300235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local effects of TL01 phototherapy in psoriasis.
    DeSilva B; McKenzie RC; Hunter JA; Norval M
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):268-9. PubMed ID: 18811869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.